Follow the 원텍 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 원텍 has logged 86 public disclosures. Market capitalisation: €431.2bn. The latest transaction was filed on 6 May 2026 (Purchase). Among the most active insiders: 최정윤. All data is openly available.
86
Insider Decl.
n/a
Thresholds
€3m
40 ops.
Buy Volume
€85,255
6 ops.
Sell Volume
30Σ signal
Buys €3m€85,255 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,153 of 29,063 companies
80.2
score / 100
Value
75
Quality
85
FCF yld11%
Earn yld7.5%
EV/EBITDA9.5x
ROE23%
Gross mgn67%
Net mgn22%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
원텍 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and manufacturing of pharmaceutical and medical products.
